“The Last Shift”
Oil on clay covered wood board by C. Michael Gibson 2020.
Welcome home to all of our courageous #CoronaHeroes who made the ultimate sacrifice 🙏💙
#cmgsees#COVID19
How reproducible is AI-enabled coronary plaque quantification?
Dr. Jonathon Leipisic and I discuss a new study published in JACC: Advances, where researchers evaluated the interobserver and intraobserver reproducibility of AI-informed coronary CT angiography (CCTA)–derived
I have not been able to locate any public announcement confirming the HERMES phase 3 trial of #Ziltivekimab in HFpEF been halted.
Does anyone have a link to a press release or a public announcement?
Some take aways from what we know about HORIZONS phase 3 trial of Lp(a) lowering
1. We know very little. We only know the primary endpoint in the entire population.
2. We do not know if some subgroups may have benefited more like those with a higher baseline Lp(a).
3. Do those
Recent guidelines give a class 1 indication (strongly recommended) to calcium score testing and Lp(a) testing. The effectiveness of both in improving outcomes has now been unsubstantiated in randomized trials.
Should they be downgraded in the guidelines? Why or why not?